Sight Sciences Inc (SGHT)
5.53
-0.28
(-4.82%)
USD |
NASDAQ |
Apr 15, 16:00
5.48
-0.05
(-0.90%)
After-Hours: 20:00
Sight Sciences Free Cash Flow (Quarterly): -6.748M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.748M |
| September 30, 2023 | -10.13M |
| June 30, 2023 | -13.59M |
| March 31, 2023 | -17.51M |
| December 31, 2022 | -15.63M |
| September 30, 2022 | -20.46M |
| June 30, 2022 | -18.65M |
| March 31, 2022 | -22.19M |
| Date | Value |
|---|---|
| December 31, 2021 | -10.88M |
| September 30, 2021 | -16.80M |
| June 30, 2021 | -12.70M |
| March 31, 2021 | -12.97M |
| December 31, 2020 | -8.852M |
| September 30, 2020 | -8.734M |
| June 30, 2020 | -5.467M |
| March 31, 2020 | -10.07M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-22.19M
Minimum
Mar 2022
-5.467M
Maximum
Jun 2020
-13.21M
Average
-12.84M
Median
Free Cash Flow (Quarterly) Benchmarks
| Ainos Inc | -1.358M |
| OpGen Inc | -3.030M |
| Zomedica Corp | 3.763M |
| LENSAR Inc | -0.525M |
| Eargo Inc (DELISTED) | -14.76M |